LongBio Pharma
LongBio Pharma is a Phase III-stage biotech company developing innovative antibody and fusion protein drugs for allergies and complement-mediated diseases. They leverage a proprietary technology platform to create biologics with independent intellectual property rights, such as LP-003, a high-affinity anti-IgE antibody, and LP-005, a bi-functional anti-C3&C5 antibody. These drugs aim to offer superior efficacy and cost-effectiveness compared to existing treatments.
Buy Funded Startups lists
Funding Round: Series B2
Funding Amount:
Date: 24-Sep-2024
Investors: Qiming Venture Partners
Markets: Biotechnology, Pharmaceuticals, Medical
HQ: Suzhou, Jiangsu, China
Founded: 2020
Website: http://www.longbio.com/
Crunchbase: https://www.crunchbase.com/organization/longbio-pharma
Leave a Comment
Comments
No comments yet.